ロード中...
EGFR and KRAS mutation coexistence in lung adenocarcinomas
Lung cancer is one of the most common causes of cancer deaths. The development of EGFR targeted therapies, including monoclonal antibodies and tyrosine kinase inhibitors have generated an interest in the molecular characterization of these tumours. KRAS mutations are associated with resistance to EG...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
DiagnomX
2015-04-01
|
| シリーズ: | Diagnostic Pathology |
| 主題: | |
| オンライン･アクセス: | http://www.diagnosticpathology.eu/content/index.php/dpath/article/view/13 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|